{"disease":{"id":"moderate-cognitive-impairment","name":"moderate cognitive impairment"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02293915","title":"An Efficacy and Safety Study of Sodium Oligo-mannurarate (GV-971) Capsule for the Treatment of Alzheimer's Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":818,"lead_sponsor_name":"Shanghai Greenvalley Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT04124029","title":"Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"VA Office of Research and Development","has_results":false},{"nct_id":"NCT05102201","title":"Effect of the Group-based Paro Intervention on Physiological and Psychological Outcomes","phase":"NA","overall_status":"COMPLETED","enrollment_count":118,"lead_sponsor_name":"National Tainan Junior College of Nursing","has_results":false},{"nct_id":"NCT05117502","title":"Foundations in Developing Precision Cognitive Restoration","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"VA Office of Research and Development","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}